Dr.Govindan is currently Professor at Washington University school Of Medicine and affiliated to Barnes-Jewish Hospital, Siteman Cancer Center. He has received MD, MBBS degrees from University of Pondicherry, University of Madras, India. He is board certified in American Board of Internal Medicine
1997, American Board of Internal Medicine (Medical Oncology), American Board of Internal Medicine (Hematology).
His publications are as follows:
Genomic alterations in lung adenocarcinoma. Devarakonda S, Morgensztern D, Govindan R Lancet Oncol. 2015 Jul; 16(7)e342-51. doi: 10.1016/S1470-2045(15)00077-7.
Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. Bezjak A, Temin S, Franklin G, Giaccone G, Govindan R, Johnson ML, Rimner A, Schneider BJ, Strawn J, Azzoli CG J Clin Oncol. 2015 Jun 20; 33(18)2100-5. doi: 10.1200/JCO.2014.59.2360.
Overcoming resistance to targeted therapy for lung cancer. Govindan R N Engl J Med. 2015 Apr 30; 372(18)1760-1. doi: 10.1056/NEJMe1500181.